Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.53 |
| ▸ | CA2 | P00918 | 4/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA7 | P43166 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.47 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24682887 | 0.93 | NPC1 (0.51) | CA1CA2TDP1CA12CA7 | |
| SCHEMBL9629692 | 0.87 | CFTR (0.49) | CA1CA2TDP1CA12CA7 | |
| SCHEMBL13864934 | 0.85 | TDP1 (0.56) | CA1CA2TDP1MAPTALDH1A1 | |
| SCHEMBL5360433 | 0.85 | CA1 (0.53) | CA1CA2TDP1CA12CA7 | |
| SCHEMBL385370 | 0.84 | LMNA (0.60) | CA1CA2TDP1CA12CA7 | |
| SCHEMBL15528792 | 0.83 | CA1 (0.52) | CA1CA2TDP1CA12CA7 | |
| SCHEMBL1033729 | 0.83 | MLYCD (0.61) | CA1CA2TDP1CA12CA7 | |
| SCHEMBL14488091 | 0.82 | NOTUM (0.57) | CA1CA2TDP1CA12CA7 | |
| SCHEMBL2549591 | 0.82 | CA1 (0.55) | CA1CA2TDP1CA12CA7 | |
| SCHEMBL8336883 | 0.82 | CA1 (0.55) | CA1CA2TDP1CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230244148-A1 | EUV RESIST UNDERLAYER FILM-FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2023-08-03 | — | — | US | disclosed |
| US-20220281820-A1 | DIAZIRINE-BASED MOLECULES AND USES THEREOF | XLYNX MATERIALS INC. (CA) | 2022-09-08 | — | — | US | disclosed |
| US-20170255100-A1 | DRY FILM STRUCTURE | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. | 2017-09-07 | — | — | US | disclosed |
| US-5656401-A | Electroluminescent device comprising oxadiazole compounds luminescent material, oxadiazole compounds for the device, and method of producing oxadiazole compounds | RICOH COMPANY, LTD. (JP) | 1997-08-12 | — | — | US | disclosed |
| US-5610309-A | Electroluminescent device comprising oxadiazole compounds luminescent material, oxadiazole compounds for the device, and method of producing oxadiazole compounds | RICOH COMPANY, LTD. (JP) | 1997-03-11 | — | — | US | disclosed |
| US-5597925-A | CYCLIZATION | RICOH COMPANY, LTD. (JP) | 1997-01-28 | — | — | US | disclosed |
| US-5420288-A | Electron transporting material, planar displays | RICOH COMPANY, LTD. (JP) | 1995-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220281820-A1 | DIAZIRINE-BASED MOLECULES AND USES THEREOF | DDT, CDH1, DCLRE1A | CA1 2365/4885CA2 2769/4885TDP1 476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.